跳至主要内容
临床试验/NCT01126034
NCT01126034已完成不适用

Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2007年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
1
主要终点
Discontinuation of metoclopramide therapy

研究概览

简要总结

The investigators hypothesized that:

  1. an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

性别
All
接受健康志愿者
是

入选标准

  • •Physicians at University of Pennsylvania Health System who ordered an active metoclopramide prescription with a questionable indication.

排除标准

  • •Physicians-in-training (e.g., residents, fellows)
  • •Physicians how were investigators on this study
  • •Physicians serving on the the University of Pennsylvania Drug Use and Effects Committee or Information Technology Oversight Board

研究组 & 干预措施

intervention

Experimental

Physicians in the intervention group were mailed a written feedback letter regarding their patients who were prescribed questionable metoclopramide therapy. Non-intervention providers received no letter. The letter consisted of the following components:

  1. The name and medical record # of the patients involved
  2. Information regarding the metoclopramide prescription: dates, dosage, indication recorded, and the duration of therapy
  3. A reminder of the adverse effect of long-term metoclopramide therapy
  4. A recommendation to consider having the patient undergo a trial of metoclopramide discontinuation if appropriate, and documentation of a discussion of risk and benefits of metoclopramide therapy with patients
  5. A request that the physician document the discontinuation trial in the electronic medical record

干预措施: intervention letter (Other)

non-intervention

No Intervention

No intervention letters were sent to subjects in this arm

结局指标

主要结局

Discontinuation of metoclopramide therapy

时间窗: 12 weeks after intervention period

Twelve weeks after the intervention period, we searched the medical records of patients in the intervention and non-intervention groups to determine whether discontinuation of metoclopramide therapy had taken place.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验